Treat all policies saw increased access, uptake of antiretroviral treatment among teenagers who had lived with the virus from infancy

By on .

Well into the era of effective treatment for HIV, a question contributed to a lag in access to the life-saving antiretroviral drugs in resource limited countries: If everyone was eligible for the medicine, would those who need it most urgently be crowded out? Just the opposite, a study tracking data on antiretroviral treatment initiation among […]

50th Union World Conference on Lung Health: Socioeconomic support improves TB prevention

By on .

HYDERABAD, INDIA – Accelerating efforts to prevent tuberculosis wherever it is treated has been the rallying cry in Hyderabad during this conference. One study shows that providing financial incentives plus social support not only improves TB treatment completion but increases TB screening and preventative therapy uptake among household members of TB patients. “TB is the archetypal […]

50th Union World Conference on Lung Health: Prevention trial targets multidrug-resistant TB

By on .

HYDERABAD, INDIA – The National Institute of Allergy and Infectious Diseases is investing $70 million in a phase III clinical trial assessing the use of tuberculosis treatments in preventing multidrug-resistant tuberculosis infection among high-risk individuals, including infected household contacts of MDR-TB patients and people living with HIV, institute officials announced here. The trial will compare the […]

50th Union World Conference on Lung Health: TB drug price drop aims to accelerate access to improved preventive therapy

By on .

HYDERABAD, INDIA – A Global Fund to Fight AIDS, Tuberculosis and Malaria, Unitaid and pharmaceutical company agreement will reduce the price of a three-month course of rifapentine – a key drug used in preventive therapy against tuberculosis – by 66% in 100 low- and middle-income countries, officials from Unitaid and pharmaceutical company Sanofi announced here […]

50th Union World Conference on Lung Health: NIH announces $30 million for research to spur TB vaccine development

By on .

HYDERABAD, INDIA –  The National Institute of Allergy and Infectious Diseases will dedicate $30 million in new funding to accelerate development of new vaccines against tuberculosis. The announcement of the funding, which will be used to establish centers of immunology research at U.S. institutions, came during the same session researchers announced that for the first time […]

50th Union World Conference on Lung Health: Vaccine candidate shows effectiveness in preventing active TB disease

By on .

HYDERABAD, INDIA – The world is one major step closer to a vaccine against tuberculosis, researchers said here, with results from a clinical trial of an investigational candidate showing 50% efficacy in preventing latent TB infection from progressing to active TB disease that was sustained three years after the start of the study. “We have […]

More than 20 years after the advent of effective ART, hospitalizations, readmissions for HIV-related illnesses in southern U.S. highlight inequities

By on .

With the discovery of combination antiretroviral treatment in 1996 came a remarkable turning point in the United States epidemic: Not only were people living with HIV living longer, they were staying out of the hospital, with admissions of people whose immune systems had been devastated by the virus dropping steadily, and lengths of stay for […]

What we’re reading: Harm in immigrant detention facilities and what needs to happen when children die in U.S. custody

By on .

A natural death: The political battlefield of infections and migrant children’s bodies – Tracing the events surrounding the death of eight-year-old Felipe Alonso Gomez in U.S. custody, Dr. Mark Travassos makes a compelling case for advocacy and action to expose and end harrowing violations of health and human rights in immigrant detention facilities. From the […]

Integrating services means thinking outside silos

By on .

The following is a guest post by Jay Gribble of Health Policy Plus and Alyson Lipsky of RTI and Health Policy Plus Donors, implementers, and governments alike have pursued health service delivery integration to achieve cost-efficient health outcomes. Yet, often driven by the needs of a specific health issue, programs are put into silos without […]

DRC Ebola PHEIC continues amid ongoing obstacles while vaccine approval represents “major milestone” for future responses

By on .

While the committee examining the Ebola epidemic in the Democratic Republic of Congo emerged today from its 5th meeting with the conclusion that transmissions of the virus there continues to pose a public health emergency of international concern (or PHEIC), news on the vaccine used to control the outbreak represented game-changing developments for the control […]